Research progress in intravesical instillation for non-muscle invasive bladder cancer
Bladder cancer is the most common malignant tumor of the urinary system, which seriously affects patients’ health and life. Transurethral resection of bladder tumor is the main treatment for non-muscle invasive bladder cancer (NMIBC), whereas high recurrence rate after surgery remains the main chall...
Main Author: | Yang Haihong, Shang Panfeng, Liu Jianbing |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Office of Journal of New Medicine
2023-09-01
|
Series: | Xin yixue |
Subjects: | |
Online Access: | https://www.xinyixue.cn/fileup/0253-9802/PDF/1695791187478-937136468.pdf |
Similar Items
-
The Management of Non-Invasive Bladder Tumours with Doxorubicin Intravesical Instillation after Transurethral Resection
by: Musa I Al-Gallab, et al.
Published: (2009-04-01) -
Intravesical Instillation of Norketamine, a Ketamine Metabolite, and Induced Bladder Functional Changes in Rats
by: Chung-Hsin Yeh, et al.
Published: (2021-06-01) -
Replacement Instead of Discontinuation of Bacillus Calmette-Guérin Instillation in Non-Muscle-Invasive Bladder Cancer
by: Po-Ting Lin, et al.
Published: (2023-02-01) -
Instillation Strategies for Non-Muscle-Invasive Bladder Cancer in the Bacillus Calmette-Guerin Shortage Era: A Simple Solution for BCG Discontinuation
by: Lin PT, et al.
Published: (2022-11-01) -
Is switching intravesical chemotherapeutic agents beneficial in short-term recurrent high-risk non-muscle-invasive bladder tumors? A 5-year retrospective study
by: Shuaiqi Chen, et al.
Published: (2024-01-01)